Redeye believes the sharp share price decline constitutes an attractive opportunity for the long-ter...
Redeye comments on the outcome of Binero’s rights issue, which brings in a total of cSEK0.
Redeye takes a positive view of Meta's entrance into the alternative distribution market as a conseq...
Q2 report due on Friday 14 July Estimates fine-tuned Q2e EBIT margin of 6.
Redeye takes a positive stance on the news that Tobii Dynavox has entered into an agreement to acqui...
S2Medical har tagit fram en ny strategi där resurser läggs på befintliga produkter vilket ska bidra ...
We update our base case to reflect the new timelines for the US submission and Aladote.
Buys wooden furniture & components manufacturer Hedlunda Adds ~46% to PF EBITDA for '23e 3.
Redeye leaves a short comment following the announcement of completed patient recruitment in Initiat...
Q3 – fullt fokus på patientrekrytering Diamyd släppte under gårdagen sin Q3-rapport för det brutna r...
Tidigare kvartals investeringar i marknadsföring återspeglas i lönsamhet Omsättningen i kvartalet up...
Redeye is positive about the last week’s strong order flow, which is highly important for the compan...
Redeye initiates coverage of Lifecare, an innovative medtech company offering a next-generation cont...
Mendus has provided an update on its development plans for its lead cancer vaccine, vididencel, prim...
Metacon växte intäkterna i Q1 och resultatet var negativt.
Redeye comments on the EU approval of MOB-015 and the new two-step approach to the EU launch.
With the Q1-report presented, it is clear that STENOCARE A/S (“STENOCARE” or the “Company”), has lai...
AVTECH has announced an extension of its Southwest agreement, which holds a value of SEK38m-52m over...
85% organic growth in Q2e and EBIT of SEK 61m H1 announced orders +52% y-o-y supports 2023e growth F...
Scandinavian Astor Group (”Astor Group” eller ”bolaget”) meddelade den 26 juni att dotterbolaget Mar...
